On a humid morning in August 2024, far from any hospital ward or funeral ground, India quietly reached a small scientific milestone. In Rohtak city in the northern state of Haryana, a volunteer rolled up their sleeve and became the first person to be enrolled in the final-stage human trial of what could be the country’s first indigenous, single-shot dengue vaccine.
There was no ribbon-cutting. No applause. No sense of arrival.
